200
Participants
Start Date
July 31, 2010
Primary Completion Date
May 31, 2011
Study Completion Date
June 30, 2011
Multimeric-001, 500 mcg
Adjuvanted Multimeric-001 was administered twice with an interval of 19-23 days.
Adjuvanted PBS
Adjuvanted PBS was administered twice with an interval of 19-23 days.
PBS and TIV 15%
PBS (Phosphate Buffered Saline) was administered twice with an interval of 19-23 days and then 60 days later a 15% dose of commercial seasonal trivalent vaccine (season 2011) was administered.
PBS and TIV 50%
PBS (Phosphate Buffered Saline) was administered twice with an interval of 19-23 days and then 60 days later a 50% dose of commercial seasonal trivalent vaccine (season 2011) was administered.
Clinical Research Center, Hadassah Medical Center, Jerusalem
Clinical Research Center, Tel-Aviv Sourasky Medical Center, Tel Aviv
Lead Sponsor
BiondVax Pharmaceuticals ltd.
INDUSTRY